338 related articles for article (PubMed ID: 11760611)
1. [Treatment of rheumatoid arthritis by inhibition of tumor necrosis factor with infliximab or etanercept].
Verhoeven AC; Boers M
Ned Tijdschr Geneeskd; 2001 Nov; 145(47):2294-5. PubMed ID: 11760611
[No Abstract] [Full Text] [Related]
2. The role of tumor necrosis factor inhibitors in patients with RA.
Trethewey P
JAAPA; 2002 Sep; 15(9):23-4, 27, 30 passim. PubMed ID: 12395668
[No Abstract] [Full Text] [Related]
3. Emerging biologic drugs for the treatment of rheumatoid arthritis.
Puppo F; Murdaca G; Ghio M; Indiveri F
Autoimmun Rev; 2005 Nov; 4(8):537-41. PubMed ID: 16214092
[TBL] [Abstract][Full Text] [Related]
4. [Infliximab in aggressive and refractory rheumatoid arthritis. A pilot study].
Caramaschi P; Canestrini S; Biasi D; Carletto A; Scambi C; Scarperi A; Bambara LM
Recenti Prog Med; 2002 Jan; 93(1):19-24. PubMed ID: 11850995
[TBL] [Abstract][Full Text] [Related]
5. Medicare coverage of tumor necrosis factor alpha inhibitors as an influence on physicians' prescribing behavior.
DeWitt EM; Glick HA; Albert DA; Joffe MM; Wolfe F
Arch Intern Med; 2006 Jan; 166(1):57-63. PubMed ID: 16401811
[TBL] [Abstract][Full Text] [Related]
6. Infliximab treatment of rheumatoid arthritis.
Maini SR
Rheum Dis Clin North Am; 2004 May; 30(2):329-47, vii. PubMed ID: 15172044
[TBL] [Abstract][Full Text] [Related]
7. Low remission rates but long drug survival in rheumatoid arthritis patients treated with infliximab or etanercept: results from the nationwide Danish DANBIO database.
Ostergaard M; Unkerskov J; Linde L; Krogh NS; Ravn T; Ringsdal VS; Petri A; Andersen LS; Tarp U; Hansen A; Hjardem E; Hetland ML
Scand J Rheumatol; 2007; 36(2):151-4. PubMed ID: 17476624
[No Abstract] [Full Text] [Related]
8. Infliximab treatment in a patient with rheumatoid arthritis on haemodialysis.
Hammoudeh M
Rheumatology (Oxford); 2006 Mar; 45(3):357-9. PubMed ID: 16368727
[No Abstract] [Full Text] [Related]
9. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF
Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863
[TBL] [Abstract][Full Text] [Related]
10. Tumor necrosis factor alpha haplotypes versus tumor necrosis factor alpha -308 G/A polymorphism in the prediction of infliximab treatment efficacy in rheumatoid arthritis.
Mugnier B; Roudier J
Arthritis Rheum; 2004 Dec; 50(12):4075-6; author reply 4076-7. PubMed ID: 15593229
[No Abstract] [Full Text] [Related]
11. True infliximab resistance in rheumatoid arthritis: a role for lymphotoxin alpha?
Buch MH; Conaghan PG; Quinn MA; Bingham SJ; Veale D; Emery P
Ann Rheum Dis; 2004 Oct; 63(10):1344-6. PubMed ID: 15033655
[TBL] [Abstract][Full Text] [Related]
12. Anti-tumor necrosis factor therapy increases synovial osteoprotegerin expression in rheumatoid arthritis.
Catrina AI; af Klint E; Ernestam S; Catrina SB; Makrygiannakis D; Botusan IR; Klareskog L; Ulfgren AK
Arthritis Rheum; 2006 Jan; 54(1):76-81. PubMed ID: 16385498
[TBL] [Abstract][Full Text] [Related]
13. Development of new-onset psoriasis in a patient receiving infliximab for treatment of rheumatoid arthritis.
Chan CY; Browning JC; Larsen F; Hsu S
Dermatol Online J; 2008 Sep; 14(9):12. PubMed ID: 19061594
[TBL] [Abstract][Full Text] [Related]
14. [Biopharmaceuticals in the treatment of rheumatoid arthritis].
Baslund B; Bendtzen K
Ugeskr Laeger; 2008 Jun; 170(24):2108-10. PubMed ID: 18572481
[TBL] [Abstract][Full Text] [Related]
15. Infliximab for rheumatoid arthritis in a patient with tuberculosis.
Matsumoto T; Tanaka T; Kawase I
N Engl J Med; 2006 Aug; 355(7):740-1. PubMed ID: 16914717
[No Abstract] [Full Text] [Related]
16. Individualized monitoring of drug bioavailability and immunogenicity in rheumatoid arthritis patients treated with the tumor necrosis factor alpha inhibitor infliximab.
Bendtzen K; Geborek P; Svenson M; Larsson L; Kapetanovic MC; Saxne T
Arthritis Rheum; 2006 Dec; 54(12):3782-9. PubMed ID: 17133559
[TBL] [Abstract][Full Text] [Related]
17. Assessing the value of rheumatoid arthritis treatment alternatives: the potential effect of tumor necrosis factor inhibitors.
Mizutani W
Manag Care Interface; 2003 Mar; 16(3):44-50, 55. PubMed ID: 12715413
[TBL] [Abstract][Full Text] [Related]
18. Evidence that anti-tumor necrosis factor therapy with both etanercept and infliximab induces apoptosis in macrophages, but not lymphocytes, in rheumatoid arthritis joints: extended report.
Catrina AI; Trollmo C; af Klint E; Engstrom M; Lampa J; Hermansson Y; Klareskog L; Ulfgren AK
Arthritis Rheum; 2005 Jan; 52(1):61-72. PubMed ID: 15641091
[TBL] [Abstract][Full Text] [Related]
19. Necrotizing scleritis associated with rheumatoid arthritis: long-term remission with high-dose infliximab therapy.
Ashok D; Ayliffe WH; Kiely PD
Rheumatology (Oxford); 2005 Jul; 44(7):950-1. PubMed ID: 15827040
[No Abstract] [Full Text] [Related]
20. Severe refractory rheumatoid arthritis successfully treated with combination rituximab and anti-tumor necrosis factor-alpha-blocking agents.
Koumakis E; Wipff J; Avouac J; Kahan A; Allanore Y
J Rheumatol; 2009 Sep; 36(9):2125-6. PubMed ID: 19738227
[No Abstract] [Full Text] [Related]
[Next] [New Search]
